Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging

被引:1453
作者
Veiseh, Omid [1 ]
Gunn, Jonathan W. [1 ]
Zhang, Miqin [1 ]
机构
[1] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA
关键词
Magnetic nanoparticle; Molecular targeting; MRI; Contrast agents; Gene therapy; Drug release; Bioconjugation; Biological barriers; Blood Brain Barrier; Surface modification; Physicochemical properties; IRON-OXIDE NANOPARTICLES; RESONANCE CONTRAST AGENTS; SIZE-CONTROLLED SYNTHESIS; IN-VIVO EVALUATION; GENE DELIVERY; SUPERPARAMAGNETIC NANOPARTICLES; BREAST-CANCER; CLINICAL-APPLICATIONS; ANNEXIN-V; PHYSICOCHEMICAL CHARACTERISTICS;
D O I
10.1016/j.addr.2009.11.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Magnetic nanoparticles (MNPs) represent a class of non-invasive imaging agents that have been developed for magnetic resonance (MR) imaging. These MNPs have traditionally been used for disease imaging via passive targeting, but recent advances have opened the door to cellular-specific targeting, drug delivery, and multi-modal imaging by these nanoparticles. As more elaborate MNPs are envisioned, adherence to proper design criteria (e.g. size, coating, molecular functionalization) becomes even more essential. This review summarizes the design parameters that affect MNP performance in vivo, including the physicochemical properties and nanoparticle surface modifications, such as MNP coating and targeting ligand functionalizations that can enhance MNP management of biological barriers. A careful review of the chemistries used to modify the surfaces of MNPs is also given, with attention paid to optimizing the activity of bound ligands while maintaining favorable physicochernical properties. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:284 / 304
页数:21
相关论文
共 240 条
[1]   MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles [J].
Artemov, D ;
Mori, N ;
Okollie, B ;
Bhujwalla, ZM .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) :403-408
[2]   Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles [J].
Banerjee, T ;
Mitra, S ;
Singh, AK ;
Sharma, RK ;
Maitra, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) :93-105
[3]   Endocytic mechanisms for targeted drug delivery [J].
Bareford, Lisa A. ;
Swaan, Peter W. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (08) :748-758
[4]   SYNTHESIS OF VERY FINE MAGHEMITE PARTICLES [J].
BEE, A ;
MASSART, R ;
NEVEU, S .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 1995, 149 (1-2) :6-9
[5]   Delivery of therapeutic agents to the central nervous system: the problems and the possibilities [J].
Begley, DJ .
PHARMACOLOGY & THERAPEUTICS, 2004, 104 (01) :29-45
[6]   Nuclear delivery of macromolecules: barriers and carriers [J].
Belting, M ;
Sandgren, S ;
Wittrup, A .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) :505-527
[7]   Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line [J].
Bhattarai, Shanta Raj ;
Kim, Sun Young ;
Jang, Kyu Yun ;
Lee, Ki Chang ;
Yi, Ho Keun ;
Lee, Dae Yeol ;
Kim, Hak Yong ;
Hwang, Pyoung Han .
JOURNAL OF VIROLOGICAL METHODS, 2008, 147 (02) :213-218
[8]   N-Acylated chitosan stabilized iron oxide nanoparticles as a novel nano-matrix and ceramic modification [J].
Bhattarai, Shanta Raj ;
Bahadur, K. C. Remant ;
Aryal, Santosh ;
Khil, Myung Seob ;
Kim, Hak Yong .
CARBOHYDRATE POLYMERS, 2007, 69 (03) :467-477
[9]   Targeting tumors with peptides from natural sources [J].
Bhutia, Sujit K. ;
Maiti, Tapas K. .
TRENDS IN BIOTECHNOLOGY, 2008, 26 (04) :210-217
[10]   Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications - A review [J].
Bonnemain, B .
JOURNAL OF DRUG TARGETING, 1998, 6 (03) :167-174